Durations of intrauterine balloon therapy and adhesion reformation after hysteroscopic adhesiolysis: a randomized controlled trial

Reprod Biomed Online. 2020 Apr;40(4):539-546. doi: 10.1016/j.rbmo.2019.11.017. Epub 2019 Dec 10.

Abstract

Research question: Does placing an intrauterine balloon for different durations (7, 14 or 28 days) affect the recurrence of intrauterine adhesions after hysteroscopic adhesiolysis?

Design: Prospective randomized control trial involving 138 patients recruited over a 12-month period and followed up post-operatively for 15 months. The primary outcome measure was the rate of adhesion reformation at third-look hysteroscopy.

Results: At third-look hysteroscopy, 8 weeks after the initial hysteroscopy, the adhesion recurrence rate in women who had an intrauterine balloon for 28 days (20%) was significantly (P < 0.01) lower than that of women who had the balloon for 14 days (55%) or 7 days (36.8%).

Conclusions: Placing an intrauterine balloon for 28 days instead of 7 or 14 days after hysteroscopic adhesiolysis resulted in a greater reduction in the recurrence rate of adhesions. However, the study was underpowered to address whether the ongoing pregnancy rate could be improved by keeping the balloon in the uterine cavity for a longer period of time.

Keywords: Asherman syndrome; Hysteroscopic adhesiolysis; Hysteroscopy; Intrauterine adhesion; Intrauterine balloon.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Female
  • Humans
  • Hysteroscopy*
  • Prospective Studies
  • Recurrence
  • Secondary Prevention / methods
  • Time Factors
  • Tissue Adhesions / prevention & control
  • Tissue Adhesions / surgery
  • Treatment Outcome
  • Uterine Diseases / prevention & control
  • Uterine Diseases / surgery*
  • Uterus / surgery*